SITE001-0057

SITE001 (USA) › SITE001-0057

SITE001-0057

A Phase III, Randomized, Double-Blind Study of Torivumab Plus Chemotherapy Versus Placebo Plus Chemotherapy in Previously Untreated Advanced Non-Small Cell Lung Cancer · Phase III
SITE001 (USA) · Dr. Reyes
consented 2025-10-30

enrolled

AEs

4

Serious

1

Dropout signal

+0.4

Luna — Jonah Reyes

Consent

granted

Messages

2

Escalations

2 escalations

Mood (avg feeling)

ø 2.0

Meds adherence (7d)

0%

Adverse events

4

Grade 1 Decreased appetite — outcome: RECOVERED/RESOLVED; onset 2023-02-07 (study day 270); relationship: not assessed

mild assessed

Grade 3 Alopecia — outcome: RECOVERED/RESOLVED; onset 2023-01-18 (study day 250); relationship: NOT RELATED; serious criteria: hospitalization

severe serious assessed

Grade 2 Decreased appetite — outcome: RECOVERED/RESOLVED; onset 2022-08-23 (study day 102); relationship: not assessed

moderate assessed

Grade 2 Stomatitis — outcome: RECOVERED/RESOLVED; onset 2022-08-18 (study day 97); relationship: not assessed

moderate assessed

Data queries

0

No data queries. Open queries would appear here for this patient.